Federico Grossi
Director/Board Member en Endoprotech, Inc. .
Fortuna: 6 M $ al 29/02/2024
Perfil
Federico Grossi ocupa el cargo de Director Médico de Apellis Pharmaceuticals, Inc. También forma parte del consejo de administración de Endoprotech, Inc. En el pasado, el Dr. Grossi fue director de investigación clínica en Potentia Pharmaceuticals, Inc. y vicepresidente ejecutivo de Potentia Pharmaceuticals, Inc. y miembro del equipo de trasplantes de la Universidad de Louisville. Se licenció y doctoró en la Universidad de Louisville y se doctoró en la Universidad Nacional de Córdoba.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
05/01/2023 | 94 884 ( 0.08% ) | 6 M $ | 29/02/2024 |
Cargos activos de Federico Grossi
Empresas | Cargo | Inicio |
---|---|---|
Endoprotech, Inc.
Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Director/Board Member | - |
Antiguos cargos conocidos de Federico Grossi.
Empresas | Cargo | Fin |
---|---|---|
APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2023 |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Corporate Officer/Principal | 01/09/2014 |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Chief Tech/Sci/R&D Officer | 01/04/2010 |
University of Louisville | Corporate Officer/Principal | - |
Formación de Federico Grossi.
University of Louisville | Doctorate Degree |
National University of Cordoba | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Endoprotech, Inc.
Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Distribution Services |